Precigen, Inc. (PGEN)
NASDAQ: PGEN · Real-Time Price · USD
0.890
-0.019 (-2.12%)
Dec 3, 2024, 1:43 PM EST - Market open
Precigen Market Cap
Precigen has a market cap or net worth of $260.54 million as of December 3, 2024. Its market cap has decreased by -9.00% in one year.
Market Cap
260.54M
Enterprise Value
243.31M
1-Year Change
-9.00%
Ranking
Category
Stock Price
$0.89
Market Cap Chart
Since August 8, 2013, Precigen's market cap has decreased from $2.32B to $260.54M, a decrease of -88.77%. That is a compound annual growth rate of -17.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 2, 2024 | 266.20M | -20.20% |
| Dec 29, 2023 | 333.60M | 5.44% |
| Dec 30, 2022 | 316.40M | -58.75% |
| Dec 31, 2021 | 767.00M | -59.45% |
| Dec 31, 2020 | 1.89B | 112.19% |
| Dec 31, 2019 | 891.50M | -0.66% |
| Dec 31, 2018 | 897.40M | -35.47% |
| Dec 29, 2017 | 1.39B | -51.74% |
| Dec 30, 2016 | 2.88B | -17.89% |
| Dec 31, 2015 | 3.51B | 26.82% |
| Dec 31, 2014 | 2.77B | 19.88% |
| Dec 31, 2013 | 2.31B | -0.51% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AngioDynamics | 281.60M |
| Nautilus Biotechnology | 281.26M |
| Personalis | 280.47M |
| Eledon Pharmaceuticals | 278.39M |
| Abeona Therapeutics | 277.78M |
| Lifecore Biomedical | 272.89M |
| Lexeo Therapeutics | 272.13M |
| TScan Therapeutics | 269.53M |